Gracell Biotechnologies Inc (DELISTED) (GRCL:DL)
10.25
0.00 (0.00%)
USD |
NASDAQ |
Feb 22, 16:00
Gracell Biotechnologies Free Cash Flow (Quarterly)
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2023 | -41.63M |
| March 31, 2023 | |
| December 31, 2022 | |
| September 30, 2022 | |
| June 30, 2022 | -34.69M |
| March 31, 2022 |
| Date | Value |
|---|---|
| December 31, 2021 | |
| September 30, 2021 | |
| June 30, 2021 | -23.60M |
| March 31, 2021 | |
| December 31, 2020 | |
| September 30, 2020 | -28.81M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-41.63M
Minimum
Jun 2023
-23.60M
Maximum
Jun 2021
-32.18M
Average
-31.75M
Median
Free Cash Flow (Quarterly) Benchmarks
| RayzeBio inc (DELISTED) | -77.07M |
| Zai Lab Ltd | -15.76M |
| WuXi Biologics (Cayman) Inc | -- |
| Axonics Inc | 4.323M |
| I-MAB | -- |